PRODUCT
首頁

產品資訊

PRODUCT
首頁

產品資訊

Cambridge 劍橋 CANTAB 測驗 - RTI 反應時間測驗

產品型號: RTI
廠牌名稱: Cambridge Cognition
反應時間測驗(Reaction Time)
CANTAB 劍橋認知心理衡鑑系統中的注意力測驗之一

產品特點

  • 簡介:反應時間(RTI)可用以評估動作和心理反應速度,以及像是動作時間、反應時間、反應準確性和衝動性等指標的測量。
  • 施測時間:大約 3 分鐘,視實際情況而定。
  • 作業:受測者必須按住螢幕底部的一個按鈕。畫面上方會出現圓圈(簡單模式為一個圓圈,五選項模式為五個圓圈)。在每種情況下,上方的某個圓圈中會出現一個黃色點,參與者必須儘快做出反應,鬆開螢幕底部的按鈕,並點選出現黃色點的那個圓圈。
  • 測驗結果:包括簡單模式和五選項模式的反應時間和動作時間。

 


相關型錄/資訊

CANTAB Connect Research 劍橋神經認知測驗介紹

CANTAB 型錄下載

CANTAB 測驗類型簡述

產品規格

主要參考文獻

CANTAB Alzheimer’s (Dementia) Battery

  • Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ. Paired associate performance in the early detection of DAT. Journal of the International Neuropsychological Society : JINS. 2002;8(1):58-71.
  • Egerhazi A, Berecz R, Bartok E, Degrell I. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer’s disease. Progress in neuro-psychopharmacology & biological psychiatry. 2007;31(3):746-51. Epub 2007/02/10.
  • Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer’s disease. Dement Geriatr Cogn Disord. 2004;17(1-2):42-8. Epub 2003 Oct 13.
  • Greig NH, Sambamurti K, Yu QS, Brossi A, Bruinsma GB, Lahiri DK. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease. Curr Alzheimer Res. 2005;2(3):281-90.
  • Atack JR. Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA. Pharmacology & therapeutics. 2010;125(1):11-26. Epub 2009/09/23.

- 更多資訊請見: http://www.cambridgecognition.com/academic-studies/product/cantab-dementia-battery#sthash.rL7KE7eu.dpuf

 

CANTAB Schizophrenia Battery

  • Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD. Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev. 2010 Jul;34(8):1161-77. doi: 10.1016/j.neubiorev.2010.01.012. Epub 2010 Jan 25.
  • Joyce E, Hutton S, Mutsatsa S, Gibbins H, Webb E, Paul S, Robbins T, Barnes T. Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry Suppl. 2002 Sep;43:s38-44.
  • Saleem MM, Harte MK, Marshall KM, Scally A, Brewin A, Neill JC. First episode psychosis patients show impaired cognitive function--a study of a South Asian population in the UK. J Psychopharmacol. 2013 Apr;27(4):366-73. Epub 2013 Feb 20.
  • Zhornitsky S, Aubin G, Desfossés J, Rizkallah E, Pampoulova T, Lipp O, Chiasson JP, Stip E, Potvin S. Predictors of community functioning in schizophrenia and substance use disorder patients. Community Ment Health J. 2013 Jun;49(3):317-22. Epub 2012 Jul 31.
  • Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G, Fennig S, Treves I, Kron S. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry. 2010 Feb;71(2):138-49. Epub 2009 Nov 3.

- 更多資訊請見:http://www.cambridgecognition.com/academic-studies/product/cantab-schizophrenia-battery#sthash.OMAEK5Un.dpuf

詢價表單

填寫完成

您可以繼續瀏覽或轉移至產品列表!

回產品列表